Rheumatoid Arthritis clinical trials
Showing 51–100 of 104 active trials. Describe your situation to see which ones you may be eligible for.
- Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
- AETOS Shoulder System
- Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections
- Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene
- A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
- Deciphering the Genetic Architecture of Autoimmune Diseases
- Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)
- Rheumatology Diet Study
- IMPACT - AndHealth Autoimmune Research Registry
- Exactech Shoulder Post Market Clinical Follow-up Study
- Persona Revision Knee System Outcomes
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
- Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
- Rheumatology Patient Registry and Biorepository
- MDR - PMCF Study for Taperloc Complete Stems
- Maternal Autoimmune Disease Research Alliance (MADRA) Registry
- A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
- Probiotics in Adults With Rheumatoid Arthritis
- Imaging of Lymphatic Vessels in People with Rheumatoid Arthritis (RA)
- Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
- Healthier: Health Coaching for People With Rheumatoid Arthritis to Improve Mental Well-Being
- A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis
- Dynamic Treatment Regiments for Glucocorticoid Tapering
- Regulation of Mucosal Healing in Inflammatory Bowel Disease
- Creating Health Course Study for People With Rheumatological Conditions
- Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis
- Medical Trial: Appraising Medical Trial Experiences of Rheumatoid Arthritis Patients
- BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease
- Disulfiram in Rheumatoid Arthritis
- Rheumatology Biorepository
- Ketogenic Diet in Rheumatoid Arthritis (RA)
- CorEvitas Rheumatoid Arthritis (RA) Drug Safety & Effectiveness Registry
- Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert
- Electromagnetic Immunotherapy Mapping and Cytokine Forecasting Study (QSIT)
- LinkSymphoKnee (LSK) Total Knee Replacement System Study - Ultra-congruent (UC)
- Survivorship and Effectiveness of the Ortho Development® Entrada™ Hip System for Total Hip Arthroplasty
- Post Market Clinical Follow-Up Study for PROFEMUR® Preserve Classic Femoral Stem
- Post Market Clinical Follow-Up Study- EVOLUTION® Revision CCK
- G7 Freedom Constrained Vivacit-E Liners
- G7 Dual Mobility With Vivacit-E or Longevity PMCF
- Tornier HRS (Humeral Reconstruction System) Study (REVIVE)
- MDR - PMCF Study for RingLoc Bipolar Acetabular Cup and Endo II Femoral Heads
- MDR - Comprehensive Primary/Micro Stem & Versa-Dial Ti Humeral Head
- Comprehensive Reverse Shoulder Data Collection
- Comparative Autoantibody and Immunologic Cell Marker Study
- Persona SoluTion PPS Femur PMCF
- Quest to Analyze One Thousand Humans Meditating
- A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)
- G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.